Your browser doesn't support javascript.
loading
Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients.
Gavriilaki, Eleni; Papadopoulou, Anastasia; Touloumenidou, Tasoula; Stavridou, Fani; Koravou, Evaggelia-Evdoxia; Giannaki, Maria; Papalexandri, Apostolia; Karavalakis, Georgios; Batsis, Ioannis; Kourelis, Andreas; Chatzopoulou, Fani; Chatzidimitriou, Dimitrios; Sotiropoulos, Damianos; Yannaki, Evangelia; Sakellari, Ioanna; Anagnostopoulos, Achilles.
Afiliação
  • Gavriilaki E; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Papadopoulou A; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Touloumenidou T; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Stavridou F; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Koravou EE; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Giannaki M; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Papalexandri A; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Karavalakis G; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Batsis I; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Kourelis A; Microbiology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Chatzopoulou F; Microbiology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Chatzidimitriou D; Microbiology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Sotiropoulos D; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Yannaki E; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece. eyannaki@uw.edu.
  • Sakellari I; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Anagnostopoulos A; Hematology Department - Hematopoietic Cell Transplant (HCT) Unit - Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.
Bone Marrow Transplant ; 57(7): 1183-1186, 2022 07.
Article em En | MEDLINE | ID: mdl-35449455

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Limite: Humans Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Limite: Humans Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2022 Tipo de documento: Article